News and Media

January 11th-14th, 2020

The H.C. Wainwright Bioconnect – 2021 Conference

PRESENTED BY DR. BARRY LIBIN
CEO, SUSTAINED NANO SYSTEMS, LLC

September 14th, 2020

22nd Annual Global Investment Conference

THE SUSTAINED NANO SYSTEM’S WEBCAST OF DR. BARRY LIBIN’S PRESENTATION
H.C.WAINWRIGHT & CO.
22ND ANNUAL GLOBAL INVESTMENT CONFERENCE
SEPTEMBER 14-16, 2020 (VIRTUAL)

PRESENTED BY DR. BARRY LIBIN
CEO, SUSTAINED NANO SYSTEMS, LLC

WALL STREET JOURNAL July 10, 2020

LETTERS TO THE EDITOR

Achieving Prolonged Antibody Bioactivity

Luciana Borio and Scott Gottlieb’s “Antibodies Can Be the Bridge to a Vaccine” (op-ed, July 5) discusses the immediate need to develop more effective therapies against Covid-19, and Gottlieb’s previous op ed piece (May 3) discusses the challenge of developing such antibodies. Though such therapy appears promising in light of its effectiveness in reducing the risk of death from Ebola in the Democratic Republic of the Congo in a comparative treatment study by Regeneron, Gottlieb warns that the ability of these engineered antibodies in producing coronavirus fighting immune cells are temporary, resulting in only several weeks of effectiveness. This was confirmed in a WSJ interview on June 12 with Regeneron, that their new Covid19 combination drug of injected antibodies may only be capable of neutralizing the virus for a short time, perhaps requiring monthly dosing. Recently, the potential to achieve elevated antibody activity throughout extended release intervals has been shown by Sustained Nano Systems, part of the Long Island High Technology Incubator at Stony Brook University. Utilizing their proprietary Densification process, animal models indicate the prolonged bioactivity of antibody for as long as one year following a single administration.

Barry Libin

CEO, Sustained Nano Systems, LLC

Westhampton Beach, NY.

January 2019

Sustained Nano Systems, LLC to report on the extended release of medical cannabis at the Biotech Showcase in San Francisco, January 9, 2019.

December 2018

Sustained Nano Systems selected to present at the biotech showcase in San Francisco.

October 2018

Sustained Nano Systems, LLC appoints Michael P. Goodman as Chief Financial Officer and Jan S. Peterson as Senior Regulatory Affairs Director.

July 2018

Sustained Nano Systems to present at the American Academy of Ophthalmology annual convention.

March 2018

Sustained Nano Systems achieves positive in-vitro results on long term sustained delivery of Latanaprost for glaucoma treatment.

January 2018

Sustained Nano Systems appoints Morton Coleman, M.D. Director of Medical Oncology Board.

October 2017

Sustained Nano Systems to present at the Life Science Summit in New York, November 1-2, 2017